Page under construction
Led by Dr Camille Roussel (Associated Professor, Université Paris Cité-APHP) with a dual appointment at the BioTiGR research unit and the Necker Hospital Hematology Laboratory, our group investigates the spleen’s central role in the pathophysiology of hemolytic red blood cell disorders.
Our mission is to bridge fundamental erythrocyte biology with clinical excellence to improve patient care. We focus on constitutional (sickle cell disease, spherocytosis, G6PD deficiency) and acquired hemolytic anemias (AIHA, PNH), with a dedicated goal of identifying and validating new therapeutic options to mitigate hemolysis and its systemic complications.
This work is deeply integrated with our clinical activity at the Necker Hospital Hematology Laboratory. As a Reference Laboratory (LBMR), we specialize in the quantification of pocked cells, a key biomarker of splenic function. By bridging bench research with hospital expertise, we focus on evaluating markers of functionality and their correlation with the clinical complications associated with hyposplenism.
Hereditary Spherocytosis is an inherited disorder characterized by rigid, spherical red blood cells (spherocytes) that undergo premature destruction by the spleen. Using an innovative microsphiltration technique that mimics the physical constraints of splenic vvvslits, our group investigates how the spleen contributes to both the elimination and the remodeling (formation) of spherocytes. We are currently exploring whether specific genetic mutations correlate with retention rates in our biomimetic model to better predict clinical disease severity. Ultimately, our research aims to identify novel therapeutic compounds capable of enhancing red blood cell filterability. By employing both targeted candidate and high-throughput screening approaches, we seek to develop medical alternatives that could reduce the need for splenectomy.
This work is supported by l’Agence Nationale de la Recherche et l’American Society of Hematology (Narla and Murthy Family Global Research Award).
In Sickle Cell Disease (SCD), abnormal hemoglobin (HbS) causes red blood cell sickling and coagulation activation. In collaboration with Hémostase, inflammation, thrombose (HITh) team (Inserm, Université Paris-Saclay). We explore the non-hemostatic roles of Protein S, focusing on its impact on erythrophagocytosis and endothelial cell adhesion. Our research aims to identify how modulating these pathways could offer new pharmacological targets to prevent vaso-occlusive crises.
The spleen is the only organ responsible for clearing intra-erythrocytic inclusions. A loss of function leads to the persistence of red blood cells containing vacuoles called “pocked cells”. A high proportion of pocked cells is a validated biomarker for hyposplenism, which portends risk life threatening infectious and thrombo-embolic complications. Within the Reference Laboratory (LBMR) at Necker Hospital, we have established routine pocked cell quantification, enabling the assembly of a unique clinical cohort to study the correlation between markers and the long-term complications of hyposplenism, and to Identify and characterize which specific underlying pathologies are major drivers of hyposplenism.
Demagny Julien, Roussel Camille, Le Guyader Maïlys, Guiheneuf Eric, Harrivel Véronique, Boyer Thomas, Diouf Momar, Dussiot Michaël, Demont Yohann, Garçon Loïc
EBioMedicine, 83 104209 (2022)
<h4>Background</h4>Schistocyte counts are a cornerstone of the diagnosis of thrombotic microangiopathy syndrome (TMA). Their manual quantification is complex and alternative automated methods suffer from pitfalls that limit their use. We report a method combining imaging flow cytometry (IFC) and artificial intelligence for the direct label-free and operator-independent quantification of schistocytes in whole blood.<h4>Methods</h4>We used 135,045 IFC images from blood acquisition among 14 patients to extract 188 features with IDEAS® software and 128 features from a convolutional neural network (CNN) with Keras framework in order to train a support vector machine (SVM) blood elements’ classifier used for schistocytes quantification.<h4>Finding</h4>Keras features showed better accuracy (94.03%, CI: 93.75-94.31%) than ideas features (91.54%, CI: 91.21-91.87%) in recognising whole-blood elements, and together they showed the best accuracy (95.64%, CI: 95.39-95.88%). We obtained an excellent correlation (0.93, CI: 0.90-0.96) between three haematologists and our method on a cohort of 102 patient samples. All patients with schistocytosis (>1% schistocytes) were detected with excellent specificity (91.3%, CI: 82.0-96.7%) and sensitivity (100%, CI: 89.4-100.0%). We confirmed these results with a similar specificity (91.1%, CI: 78.8-97.5%) and sensitivity (100%, CI: 88.1-100.0%) on a validation cohort (n=74) analysed in an independent healthcare centre. Simultaneous analysis of 16 samples in both study centres showed a very good correlation between the 2 imaging flow cytometers (y=1.001x).<h4>Interpretation</h4>We demonstrate that IFC can represent a reliable tool for operator-independent schistocyte quantification with no pre-analytical processing which is of most importance in emergency situations such as TMA.<h4>Funding</h4>None.
Array
EBioMedicine, 2022, vol.83, p.104209
Demagny Julien, Roussel Camille, Le Guyader Maïlys, Guiheneuf Eric, Harrivel Véronique, Boyer Thomas, Diouf Momar, Dussiot Michaël, Demont Yohann, Garçon Loïc
Dumas Lucie, Roussel Camille, Buffet Pierre
Frontiers in physiology, 14 1324463 (2023)
The spleen plays a dual role of immune response and the filtration of red blood cells (RBC), the latter function being performed within the unique microcirculatory architecture of the red pulp. The red pulp filters and eliminates senescent and pathological RBC and can expell intra-erythrocytic rigid bodies through the so-called pitting mechanism. The loss of splenic function increases the risk of infections, thromboembolism, and hematological malignancies. However, current diagnostic tests such as quantification of Howell-Jolly Bodies and splenic scintigraphy lack sensitivity or are logistically demanding. Although not widely available in medical practice, the quantification of RBC containing vacuoles, i.e., pocked RBC, is a highly sensitive and specific marker for hyposplenism. The peripheral blood of hypo/asplenic individuals contains up to 80% RBC with vacuoles, whereas these pocked RBC account for less than 4% of RBC in healthy subjects. Despite their value as a spleen function test, intraerythrocytic vacuoles have received relatively limited attention so far, and little is known about their origin, content, and clearance. We provide an overview of the current knowledge regarding possible origins and mechanisms of elimination, as well as the potential function of these unique and original organelles observed in otherwise “empty” mature RBC. We highlight the need for further research on pocked RBC, particularly regarding their potential function and specific markers for easy counting and sorting, which are prerequisites for functional studies and wider application in medical practice.
Roussel Camille, Serris Alexandra, Henry Benoît, Lafon Desmurs Barthelemy, Sitterlé Emilie, Bougnoux Marie Elisabeth, Argy Nicolas, Larréché Sébastien, De Montalembert Mariane, Ioos Vincent, Tantaoui Ilhame, Chambrion Charlotte, Fricot Aurélie, Rouzaud Claire, Lanternier Fanny, Lortholary Olivier, Houzé Sandrine, Jauréguiberry Stéphane, Thellier Marc, Ndour Papa Alioune, Buffet Pierre
Journal of travel medicine, 30 taad144 (2023)
Array
Journal of travel medicine, 2023, vol.30, p.taad144
Roussel Camille, Serris Alexandra, Henry Benoît, Lafon Desmurs Barthelemy, Sitterlé Emilie, Bougnoux Marie Elisabeth, Argy Nicolas, Larréché Sébastien, De Montalembert Mariane, Ioos Vincent, Tantaoui Ilhame, Chambrion Charlotte, Fricot Aurélie, Rouzaud Claire, Lanternier Fanny, Lortholary Olivier, Houzé Sandrine, Jauréguiberry Stéphane, Thellier Marc, Ndour Papa Alioune, Buffet Pierre
Claire Auditeau, Aurélie Fricot, Raphaël Gauthier, Abdoulaye Sissoko, Zeynep Cacan, Céline Gounou, Laure Joseph, Sandra Manceau, Slimane Allali, Michael Dussiot, Mickael Marin, Alexis Lavergne, Mariem Khamari, Sophie Moog, Elsa Bianchini, Laetitia Claer, Sandrine Laurance, Valentine Brousse, Sébastien Eymieux, Philippe Roingeard, Pascal Amireault, Thiago Trovati Maciel, Alain Brisson, Pierre Buffet, François Saller, Delphine Borgel, Camille Roussel
American Journal of Hematology, 101 26-40 (2025)
The major anticoagulant Protein S (PROS1) also contributes to the phagocytosis of apoptotic cells by bridging exposed phosphatidylserine (PtdSer) to the MerTK receptor on macrophages (efferocytosis). Whether PROS1 is involved in the splenic clearance of PtdSer-positive senescent and altered erythrocytes such as erythrocyte ghosts (eryghosts) is unknown. Here, we investigate the contribution of PROS1 and MerTK to the phagocytosis of intact RBC and eryghosts in healthy subjects and patients with sickle cell disease (SCD). We show that PROS1 enhances the phagocytosis of ionomycin-treated PtdSer-positive erythrocytes and of eryghosts generated in vitro. We confirm that eryghosts circulate in patients with SCD at higher levels than in healthy subjects and observe increased hemolysis and decreased levels of plasmatic PROS1 in patients with the highest concentration of eryghosts. The proportion of circulating eryghosts is correlated with the intensity of hyposplenism, and eryghosts are less frequently observed in sections of SCD compared to control spleens. We demonstrate that circulating eryghosts are procoagulant and adhere to endothelial cells. In SCD, PROS1 enhances their phagocytosis in a MerTK-dependent manner but has no such effect on intact erythrocytes. PROS1 is therefore involved in erythrophagocytosis, a physiological process insufficient in patients with SCD due to intense intravascular hemolysis and hyposplenism, leading to PROS1 consumption and the abnormal persistence of eryghosts in circulation. PROS1 deficiency may in turn initiate a pathogenic loop, enhancing unregulated activation of coagulation and defective clearance of procoagulant and adherent eryghosts. This deeper understanding of physiological and pathological erythrophagocytosis opens new therapeutic approaches targeting PROS1 in SCD.
Array
American Journal of Hematology, 2025, vol.101, p.26-40
Claire Auditeau, Aurélie Fricot, Raphaël Gauthier, Abdoulaye Sissoko, Zeynep Cacan, Céline Gounou, Laure Joseph, Sandra Manceau, Slimane Allali, Michael Dussiot, Mickael Marin, Alexis Lavergne, Mariem Khamari, Sophie Moog, Elsa Bianchini, Laetitia Claer, Sandrine Laurance, Valentine Brousse, Sébastien Eymieux, Philippe Roingeard, Pascal Amireault, Thiago Trovati Maciel, Alain Brisson, Pierre Buffet, François Saller, Delphine Borgel, Camille Roussel
Khadidja Fouatih, Camille Roussel, Maryse Cartigny, Muriel Houang, Lise Duranteau, Zeina Chakhtoura, Anne-Sophie Lambert, Marie-Agathe Trouvin, Barbara Girerd, Ekaterina Belozertseva, Delphine Borgel, Stephanie Franchi-Abella, Jérôme Bouligand, Maureen Lopez, Kenneth Chappell, Pierre Buffet, Ines Belguith, Claire Bouvattier, Abd El Kader Ait Tayeb
Endocr Connect, 14 250549 (2025)
Purpose
Steroidogenic factor 1 (SF-1), encoded by NR5A1, is essential for spleen development and function. NR5A1 variants have been linked to abnormal spleen development. Hyposplenism exposes individuals to severe complications with potentially serious sequelae. This study aimed to determine the prevalence and principal features of hyposplenism in a cohort of French patients with NR5A1 variants.
Methods
We conducted a cross-sectional multicentre ancillary study among 34 patients carrying heterozygous NR5A1 variants within the GR-EX cohort, which includes individuals from families affected by red blood cell diseases. All participants underwent splenic imaging (ultrasound, CT, or MRI) and pocked red blood cell (pRBC) quantification. pRBC thresholds of 20% corresponded to normal splenic function, moderate hyposplenism, and severe hyposplenism, respectively. The primary endpoints were the prevalence of hyposplenism and its severity.
Results
Functional hyposplenism was observed in 21/34 patients (61.7%), including 16/34 (47%) with severe forms. Morphological spleen abnormalities were identified in 15/34 patients (44.1%), with asplenia in 4/34 (11.7%). All patients with morphological spleen abnormalities on imaging also presented functional hyposplenism. Conversely, 6/21 patients (28%) with functional hyposplenism showed no morphological abnormalities on imaging. No association was found between NR5A1 genotypes, gonadal phenotypes, and splenic anomalies.
Conclusions
Functional hyposplenism was frequent in this cohort of patients carrying NR5A1 variants, regardless of genotype and gonadal phenotype. Assessing splenic function is mandatory to help manage these patients. Preventive measures are also critical when hyposplenism is present.
Array
Endocr Connect, 2025, vol.14, p.250549
Khadidja Fouatih, Camille Roussel, Maryse Cartigny, Muriel Houang, Lise Duranteau, Zeina Chakhtoura, Anne-Sophie Lambert, Marie-Agathe Trouvin, Barbara Girerd, Ekaterina Belozertseva, Delphine Borgel, Stephanie Franchi-Abella, Jérôme Bouligand, Maureen Lopez, Kenneth Chappell, Pierre Buffet, Ines Belguith, Claire Bouvattier, Abd El Kader Ait Tayeb
Address
Biotigr Lab
Team 4 UMR-S 1134 INSERM
Université de Paris
Hôpital NECKER – Enfants Malades
149 rue de Sèvres
75015 Paris, France